Debate: Do all patients with heart failure require automatic implantable defibrillators for the prevention of sudden death?
Recent clinical trials indicate that approximately two-thirds of patients in New York Heart Association (NYHA) class II and III, who comprise almost 90% of patients with heart failure, die suddenly. Patients in NYHA class IV usually die of progressive heart failure. Implantation of implantable cardi...
Na minha lista:
| Publicado no: | Curr Control Trials Cardiovasc Med |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2000
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59608/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11714419/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-1-2-095 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|